| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 85,317 | 47,000 |
| Depreciation and amortization | 143,495 | 96,027 |
| Amortization of debt issuance costs | 3,513 | 2,278 |
| Equity-based compensation expense | 25,257 | 19,226 |
| Deferred income taxes | 3,309 | -8,753 |
| Debt extinguishment costs | -1,269 | -1,269 |
| Legal settlements expense | 3,504 | 3,504 |
| Loss on impairment | 1,452 | 1,452 |
| Gain on sale of property | 8,715 | 8,715 |
| Other | -1,907 | -1,128 |
| Accounts receivable, net | 64,958 | 42,660 |
| Other current assets | 17,590 | 3,797 |
| Other assets | 10,865 | 7,684 |
| Accounts payable and other accrued liabilities | 33,584 | 27,684 |
| Accrued salaries and benefits | 5,158 | -3,940 |
| Other liabilities | 12,554 | 20,962 |
| Net cash provided by operating activities | 218,191 | 144,981 |
| Cash paid for acquisitions, net of cash acquired | 8,165 | 8,165 |
| Cash paid for capital expenditures | 478,617 | 342,378 |
| Proceeds from sale of property and equipment | 23,151 | 16,623 |
| Other | 145 | 101 |
| Net cash used in investing activities | -463,776 | -334,021 |
| Borrowings on long-term debt | 1,200,000 | 1,200,000 |
| Borrowings on revolving credit facility-New Credit Facility | 875,000 | 830,000 |
| Principal payments on revolving credit facility | 1,035,000 | 1,035,000 |
| Principal payments on long-term debt | 8,125 | 4,063 |
| Repayment of long-term debt | 670,856 | 670,856 |
| Payment of debt issuance costs | 18,615 | 18,615 |
| Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises | -3,953 | -3,716 |
| Repurchase of common stock | 50,034 | 50,034 |
| Contributions from noncontrolling partners in joint ventures | 5,000 | - |
| Distributions to noncontrolling partners in joint ventures | 3,877 | 1,990 |
| Cash paid for contingent consideration | 1,500 | 1,500 |
| Other | -67 | -70 |
| Net cash provided by financing activities | 287,973 | 244,156 |
| Net increase (decrease) in cash and cash equivalents | 42,388 | 55,116 |
| Cash and cash equivalents at beginning of period | 76,305 | - |
| Cash and cash equivalents at end of period | 118,693 | - |
Acadia Healthcare Company, Inc. (ACHC)
Acadia Healthcare Company, Inc. (ACHC)